scPharmaceuticals Inc.
NASDAQ:SCPH
Overview | Financials
Company Name | scPharmaceuticals Inc. |
Symbol | SCPH |
Currency | USD |
Price | 4.32 |
Market Cap | 216,124,416 |
Dividend Yield | 0% |
52-week-range | 3.24 - 6.71 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. John H. Tucker |
Website | https://www.scpharmaceuticals.com |
An error occurred while fetching data.
About scPharmaceuticals Inc.
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD